fbpx
March 2, 2020

Novel Treatment Offers New Hope for Peripheral Neuropathy Novel Treatment Offers New Hope for Peripheral Neuropathy

NATIONAL HARBOR, Maryland ― Combined electrochemical treatment (CET), a technique that uses local nerve blocks in conjunction with electric cell signaling, regenerates nerve fibers and significantly […]
February 28, 2020

Benefits of Switching to Tenecteplase for Stroke Thrombolysis Benefits of Switching to Tenecteplase for Stroke Thrombolysis

Switching from alteplase to tenecteplase as the thrombolytic used routinely for acute ischemic stroke is having multiple benefits for one US hospital system. Tenecteplase was developed […]
February 28, 2020

Increased Risk of Infection Seen in Patients With MS Increased Risk of Infection Seen in Patients With MS

WEST PALM BEACH, Florida — Patients with multiple sclerosis (MS) are at increased risk for most types of infection, with the highest risk associated with renal […]
February 28, 2020

Cancer Increase Seen in Modern Era of MS Drugs Cancer Increase Seen in Modern Era of MS Drugs

WEST PALM BEACH, Florida — Cancer incidence rates among patients with multiple sclerosis (MS) treated after the advent of immune therapies show an increase compared with […]
February 28, 2020

Pregnancy Linked to Later Onset of Progressive MS Pregnancy Linked to Later Onset of Progressive MS

WEST PALM BEACH, Florida — Women who have no history of a full-term pregnancy show an earlier onset of progressive multiple sclerosis (MS) compared with those […]
February 28, 2020

Ping-Pong Serves Up Improved Motor Symptoms in Parkinson’s Ping-Pong Serves Up Improved Motor Symptoms in Parkinson’s

Dr Shinsuke Fujioka Playing table tennis, also known as ping-pong, appears to improve motor symptoms in patients with Parkinson’s disease (PD), new research suggests. The results […]
February 28, 2020

FDA OKs First Orally Disintegrating CGRP for Migraine FDA OKs First Orally Disintegrating CGRP for Migraine

The US Food and Drug Administration (FDA) has approved rimegepant (Nurtec ODT, Biohaven), the first calcitonin gene-related peptide (CGRP) receptor antagonist available in a fast-acting orally […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0